ʻO ka kūʻaiʻana i ka waiwai o Valneva hiki ke loaʻa ka waiwai i ka wā lōʻihi. ʻO kēia ka mahele o ka hui biotechnology Franco-Austrian Valneva, i helu ʻia ma ke kumukūʻai kūʻai ʻo Paris. ʻO kahi ʻāpana o ka SBF 120 stock index, ʻo Valneva kahi ʻoihana waiwai nui. E ʻike ma kēia ʻatikala pehea e kūʻai ai i nā ʻāpana Valneva ma ke ala maikaʻi loa.
ʻO VALNEVA SE (VLA.PA) ke kumu kūʻai ma ka manawa maoli
I kēia manawa hiki iā ʻoe ke kūʻai i ke kumukūʻai VALNEVA SE ma ke kumukūʻai o €2,78 no kēlā me kēia. Mai ka hoʻomaka ʻana o ka lā, ua hoʻololi ke kumukūʻai VLA.PA e -1.8361598%.
I ka wehe ʻana, ʻo ke kumukūʻai o VALNEVA SE he €2,89. I ka wā o ke kau, ʻo ke kiʻekiʻe i loaʻa e ke kumu kūʻai he €2,89 a ʻo ka haʻahaʻa haʻahaʻa he €2,73 a ʻo ke kumukūʻai pani o ka lā he €2,83.
Pono ʻoe e kūʻai i ka waihona VALNEVA - Nā Kiʻi Kiʻi
Ma luna o hoʻokahi makahiki (52 pule i hala iho nei) ua hōʻea ke kumukūʻai o VALNEVA SE i kahi kiʻekiʻe o €4,30, a ʻo ka haʻahaʻa loa i hiki i nā pule he 52 i hala he €1,73.
I loko o nā lā kālepa 5 hope loa o VALNEVA SE (VLA.PA) ua ulu ke kumukūʻai penei:
Pono ʻoe e kūʻai i nā ʻāpana VALNEVA SE i Mei?
I kēia manawa, ʻo ke kumu kūʻai o VALNEVA SE he €2,78 a e uku i ka puʻunaue o kēlā me kēia mahele! ʻO ka VALNEVA SE ka uku puʻunaue % no ka makahiki inā kūʻai ʻoe i nā ʻāpana VALNEVA SE ma ke kumukūʻai o kēia manawa.
E noʻonoʻo hoʻi i ke koho ʻana i kahi mea kūʻai aku i loaʻa ka pono o ka hāʻawi ʻana i kahi hāʻawi piha no kūʻai i nā kumukūʻai mai nā wahi a pau o ka honua! E ʻae kēia iā ʻoe e hoʻololi i kāu kōpili ma hope.
ʻO ka manaʻo a me ke kumu kūʻai o nā mea loiloi ma nā ʻāpana VALNEVA SE
VALNEVA SE Puʻunaue Puʻunaue
ʻAʻole hoʻokaʻawale ʻo VALNEVA SE i kēia manawa i nā ʻāpana. No laila, ʻaʻole hiki iā ia ke hana i ka loaʻa passive i kēia manawa. ʻO ia ke ʻano o kēia kumukūʻai e hāʻawi wale ana i nā loaʻa kālā kūpono inā piʻi ke kumukūʻai i ka wā e hiki mai ana a kūʻai hou ʻia ma ke kumukūʻai kiʻekiʻe ma mua o ke kumu kūʻai.
Ka poe kuleana o VALNEVA SE
Eia nā mea kuleana o kēia manawa o ka hui VALNEVA SE:
- Groupe Grimaud La Corbière SA – 8,711%
- PFIZER, INC. – 6,857%
- Bpifrance Participations SA / PRIVATE EQUITY/ – 6,203%
- Deep Track Capital LP – 4,972%
- CDC Croissance SA – 1,486%
- Hoʻolālā Lapaʻau GmbH – 1,062%
- Apo Asset Management GmbH – 0,4827%
- Franck Grimaud – 0,4561%
- Thomas Lingelbach – 0,2768%
- Eiffel Investment Group (Private Equity) - 0,2145%
Nā mea hoʻokūkū o ka Hui VALNEVA SE
ʻOiai ʻokoʻa paha nā mea hoʻokūkū pololei ma muli o ka ʻike loea a me ka pae ʻāina, eia kekahi mau ʻoihana i manaʻo ʻia he mau mea hoʻokūkū kūpono no VALNEVA SE:
- Sanofi-Pasteur : ʻO Sanofi Pasteur, he māhele o Sanofi, kekahi o nā mea hana kano koʻikoʻi o ka honua. Hoʻomohala, hana a kūʻai aku ka Hui i nā ʻano lāʻau lapaʻau pale e kūʻē i nā maʻi maʻi like ʻole, e like me ka maʻi maʻi, polio, diphtheria, pertussis, etc. (E kūʻai i ka waiwai o Sanofi)
- Nā lāʻau lapaʻau ʻo GlaxoSmithKline (GSK). : ʻO GSK Vaccines kahi mahele o GlaxoSmithKline, kekahi o nā hui lāʻau lapaʻau nui loa o ka honua. Hoʻokumu a kūʻai aku ʻo GSK Vaccines i nā ʻano lāʻau lapaʻau like ʻole, me nā lāʻau lapaʻau no ka maʻi maʻi maʻi, ka maʻi maʻi, ka maʻi maʻi, a pēlā aku.
- Pfizer Inc. : ʻO Pfizer kahi hui lāʻau lapaʻau honua e hana ana i nā ʻano huahana lāʻau lapaʻau, me nā lāʻau lapaʻau. Ua ʻike ʻia ʻo Pfizer no kāna hoʻomohala ʻana i nā kano e like me ke kano COVID-19 i hoʻomohala ʻia me ka hui pū me BioNTech. (E kūʻai i ka waihona Pfizer)
- Hoikehonua : ʻO Moderna kahi hui biotechnology i hoʻomohala a kūʻai aku i ka maʻi maʻi COVID-19 mRNA, kekahi o nā lāʻau lapaʻau mRNA mua i ʻae ʻia no ka hoʻohana pilikia ma ka honua holoʻokoʻa. Hoʻokumu ka hui i ka hoʻomohala ʻana i nā lāʻau lapaʻau e pili ana i ka mRNA no ka nui o nā maʻi. (E kūʻai i ka waiwai Moderna)
- HanaLalo : ʻO BioNTech kahi hui biotechnology i hui pū me Pfizer e hoʻomohala i ka maʻi mRNA COVID-19. Hoʻokumu pū ʻia ka ʻoihana i ka hoʻomohala ʻana i nā lāʻau lapaʻau mRNA a me nā lāʻau lapaʻau no nā maʻi maʻi ʻē aʻe a me nā maʻi kanesa.
- Johnson & Johnson (Janssen Pharmaceuticals) : ʻO Johnson & Johnson kahi hui lāʻau lapaʻau honua e hana ana i nā ʻano huahana lāʻau lapaʻau, me nā lāʻau lapaʻau. Ua hoʻomohala kāna mahele ʻo Janssen Pharmaceuticals i ka maʻi viral vector COVID-19 Ad26.COV2.S. (E kūʻai i ka waiwai o Johnson & Johnson)
ʻO kēia mau hui, i waena o nā mea ʻē aʻe, he mau mea hoʻokūkū kūpono o Valneva ma ke kahua o nā kano a me ka pale ʻana i nā maʻi maʻi. Hiki ke ʻokoʻa ka hoʻokūkū ma muli o nā maʻi i manaʻo ʻia, nā ʻenehana i hoʻohana ʻia a me nā mākeke kikoʻī kikoʻī.
ʻO nā mea kūʻai aku o ka Hui VALNEVA SE
ʻO nā mea kūʻai aku o Valneva nā aupuni nui, nā hui olakino ākea ākea, nā hui lāʻau lapaʻau a me nā mea hoʻolaha kano. Eia kahi hiʻohiʻona o nā ʻano mea kūʻai nui o Valneva:
- Nā aupuni a me nā hui olakino lehulehu : He mau mea kūʻai koʻikoʻi nā aupuni a me nā hui olakino o Valneva, no ka mea, ʻo lākou ke kuleana no ka mālama ʻana a me ka hoʻokō ʻana i nā papahana lapaʻau no ka pale ʻana i nā maʻi maʻi. Hiki iā lākou ke kūʻai pololei mai Valneva no ka pale ʻana i ko lākou heluna kanaka mai nā maʻi kikoʻī, e like me ka maʻi Lyme a i ʻole ka encephalitis i lawe ʻia i ka tick-borne.
- Nā hui olakino honua : ʻO nā hui e like me ka World Health Organization (WHO), ka World Organization for Animal Health (OIE) a me ka Global Alliance for Vaccines and Immunization (GAVI) he mau mea kūʻai paha o Valneva. He hana koʻikoʻi lākou i ka hoʻolaha ʻana i ka lāʻau lapaʻau ma ka honua holoʻokoʻa a hiki ke kūʻai aku i nā kano mai Valneva e kākoʻo i kā lākou mau hana olakino lehulehu.
- ʻO nā hui lāʻau lapaʻau : Hiki iā Valneva ke komo i nā ʻaelike pili me nā hui lāʻau lapaʻau ʻē aʻe no ka hoʻomohala ʻana, ka hana ʻana a me ka hāʻawi ʻana i nā lāʻau lapaʻau. Hiki i kēia mau hui ke komo i nā uku milestone, nā uku kūʻai a me nā ʻano hana like ʻole.
- Nā mea hoʻolaha kano : ʻO nā mea hoʻolaha kūikawā i ka hāʻawi ʻana i nā huahana lāʻau lapaʻau a me nā lāʻau lapaʻau hiki ke lilo i mea kūʻai aku iā Valneva. Hiki iā lākou ke kūʻai aku i nā lāʻau lapaʻau mai Valneva no ka hāʻawi ʻana i nā limahana mālama ola kino, nā keʻena lapaʻau, nā halemai a me nā lāʻau lapaʻau ma nā ʻāina like ʻole.
- ʻOihana mālama ola kino : ʻOiai ʻaʻole nā mea kūʻai pololei o Valneva nā limahana mālama ola kino, he hana koʻikoʻi lākou i ka lawelawe ʻana i nā kano i nā maʻi. Hiki iā Valneva ke hana pili me nā limahana mālama ola e hoʻolako i ka hoʻomaʻamaʻa a me ka hoʻonaʻauao ʻana i ka hoʻohana kūpono ʻana i kāna mau kano.
ʻAʻole paʻa kēia mau laʻana, a ʻokoʻa paha ka papa inoa o nā mea kūʻai aku o VALNEVA SE ma muli o kāna hoʻolālā ʻoihana a me nā hoʻolālā ulu.
No ke aha e hoʻokomo ai i nā ʻāpana VALNEVA SE
ʻO ka hoʻokomo kālā ʻana ma Valneva stock hiki ke lilo i hoʻoholo hoihoi no nā kumu he nui:
- ʻO ka waihona huahana like ʻole : Hoʻomohala ʻo Valneva i nā lāʻau lapaʻau hou no ka pale ʻana i nā maʻi lele koʻikoʻi. Loaʻa i ka hui kahi waihona huahana like ʻole me nā lāʻau lapaʻau no ka maʻi Lyme, tick-borne encephalitis, chikungunya a me nā maʻi maʻi ʻē aʻe. Hiki i ka hoʻomāhuahua ʻana o ka waihona huahana ke hōʻemi i ka pilikia e pili ana i ka hilinaʻi ʻana i hoʻokahi huahana.
- ʻenehana lapaʻau kiʻekiʻe : Hoʻohana ʻo Valneva i nā kahua ʻenehana ʻokiʻoki no ka hoʻomohala ʻana i kāna mau lāʻau lapaʻau, e komo pū ana me ka ʻenehana lāʻau lapaʻau inactivated particle (IPV) a me ka ʻenehana RNA (mRNA). Hāʻawi kēia mau ʻenehana i nā pono i ka pono, palekana a me ka hiki ke hana, hiki ke hoʻonui i ka hoʻokūkū o nā huahana o ka hui ma ka mākeke.
- Paipai hoʻomohala hoʻohiki : Loaʻa iā Valneva kahi paipu hoʻomohala ikaika e komo pū ana me kekahi mau moho lāʻau lapaʻau i ka hopena o ka lāʻau lapaʻau a preclinical. ʻO ka hoʻonui ʻana i kēia mau papahana hoʻomohala hiki ke alakaʻi i ka loaʻa kālā hou a me nā manawa ulu no ka Hui i ka wā e hiki mai ana.
- Pākuʻi hoʻolālā : Ua hoʻokumu ʻo Valneva i nā pilina pili me nā hui alakaʻi a me nā ʻoihana i ka ʻoihana lāʻau lapaʻau a me ka biotechnology. Hāʻawi kēia mau pilina iā Valneva i ka loaʻa ʻana o nā kumuwaiwai hou aʻe, hiki ke hoʻomohala a me nā manawa kūʻai aku, hiki ke hoʻoikaika i kona kūlana mākeke a hoʻonui i ka ulu ʻana o ka hui.
- Ke ulu nei ka makemake no nā lāʻau lapaʻau : Ua hōʻike ka maʻi maʻi COVID-19 i ke koʻikoʻi o nā lāʻau lapaʻau i ka pale ʻana a me ka mālama ʻana i nā maʻi maʻi. Ke piʻi nei ka noi honua no nā kano, hiki iā ia ke pōmaikaʻi iā Valneva ma o ka hoʻonui ʻana i ka noi no kāna mau huahana a me ke kākoʻo ʻana i ka hoʻomohala ʻana i nā kano hou.
- ʻO ke kūpaʻa i ke olakino lehulehu : Ua kūpaʻa ʻo Valneva i ka hāʻawi ʻana i ke olakino lehulehu o ka honua ma o ka hoʻomohala ʻana i nā lāʻau lapaʻau e pale ai i nā maʻi lele koʻikoʻi. ʻO ka hoʻokomo kālā i kahi hui e kōkua i ka hoʻomaikaʻi ʻana i ke olakino a me ka maikaʻi o ka lehulehu e ʻike ʻia ma ke ʻano he hoʻopukapuka me ka hopena maikaʻi i ke kaiāulu.
ʻO ka hoʻokomo ʻana i kahi waiwai kikoʻī e like me VALNEVA SE pono i ka noiʻi hohonu a me ka hoʻomaopopo ʻana i nā pilikia a me nā manawa kūpono e pili ana i kēlā hui.
Hiki iā ʻoe ke hoʻolilo i nā kaʻana Valneva ma ka mākeke Euronext Paris (Kūʻai Kūʻai Euronex).